Localization of laminin α2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study |
| |
Authors: | M. Villanova A. Malandrini P. Sabatelli C. A. Sewry P. Toti S. Torelli J. Six G. Scarfó L. Palma F. Muntoni S. Squarzoni P. Tosi N. M. Maraldi G. C. Guazzi |
| |
Affiliation: | (1) Laboratory of Neuropathology, Institute of Neurological Sciences, University of Siena, Viale Bracci 2, I-53100 Siena, Italy Fax: 39-577-40327; e-mail: villanova@unisi.it, IT;(2) Institute of Normal and Pathological Cytomorphology, CNR Bologna, Bologna, Italy, IT;(3) Neuromuscular Unit, Department of Paediatrics and Neonatal Medicine, London, UK, GB;(4) Institute of Pathology, University of Siena, Siena, Italy, IT;(5) Department of Neurology, University of Kuopio, Kuopio, Finland, FI;(6) Department of Ophthalmology and Neurosurgery, University of Siena, Siena, Italy, IT |
| |
Abstract: | Recently, a rare form of congenital muscular dystrophy has been shown to be associated with a deficiency of laminin α2 chain, a tissue-specific component of the basal lamina. Besides muscular dystrophy, children affected with this disorder also show electrophysiological and magnetic resonance imaging evidence of white matter involvement in the central nervous system (CNS). We have studied the precise localization of laminin α2 chain in normal human brain, using specific electron microscopic techniques including thin-section fracture labeling and cryoultramicrotomy, in parallel with immunohistochemical techniques. We found that this laminin chain was localized to the basal lamina of all cerebral blood vessels, whereas blood vessels of the choroid plexus did not show any reaction. No positive reaction was found in meningeal blood vessels either. We hypothesize that in normal brain, laminin α2 may be important for the selective filtration capability of the blood-brain barrier. The lack of laminin α2 in cerebral vessels of children with laminin α2-deficient congenital muscular dystrophy may cause impaired selective filtration, leading to leakage of plasma components and damage to the CNS. Further studies should be performed on patients affected by congenital muscular dystrophy associated with laminin α2 deficiency to test this hypothesis. Received: 2 December 1996 / Revised: 26 March 1997 / Revised, accepted: 3 June 1997 |
| |
Keywords: | Basal lamina Blood-brain barrier Central nervous system Congenital muscular dystrophy Laminin α 2 |
本文献已被 SpringerLink 等数据库收录! |
|